Article citationsMore >>

Minond, D., Saldanha, S.A., Subramaniam, P., Spaargaren, M., Spicer, T., Fotsing, J.R., Weide, T., Fokin, V.V., Sharpless, K.B., Galleni, M., Bebrone, C., Lassaux, P., Hodder, P. “Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.” Biorg Med Chem, 17(14). 5027-5037. Jul. 2009.

has been cited by the following article:

Article

Combined Support-Vector-Machine-Based Virtual Screening and Docking Method for the Discovery of IMP-1 Metallo-β-Lactamase Inhibitors Supplementary Data

1School of Life Science and Technology, China Pharmaceutical University, Nanjing, P.R. China


American Journal of Biomedical Research. 2013, Vol. 1 No. 4, 120-131
DOI: 10.12691/ajbr-1-4-8
Copyright © 2013 Science and Education Publishing

Cite this paper:
Jiao Chen, Yifang Liu, Mi Fang, Hui Chen, Xingzhen Lao, Xiangdong Gao, Heng Zheng, Wenbing Yao. Combined Support-Vector-Machine-Based Virtual Screening and Docking Method for the Discovery of IMP-1 Metallo-β-Lactamase Inhibitors Supplementary Data. American Journal of Biomedical Research. 2013; 1(4):120-131. doi: 10.12691/ajbr-1-4-8.

Correspondence to: Heng  Zheng, School of Life Science and Technology, China Pharmaceutical University, Nanjing, P.R. China. Email: zhengh18@hotmail.com

Abstract

Metallo-β-lactamases can hydrolyze a broad range of β-lactam antibiotics and no effective inhibitors could be used in the clinic. Therefore, the discovery of metallo-β-lactamase inhibitors has attracted much attention in recent years. In this study, a support vector machine (SVM) that separates compounds into positives and negatives, combined with docking method was employed for virtual screening of IMP-1 metallo-β-lactamase inhibitors. Eight of the twenty five selected compounds were purchased for in vitro assays. Among them, four compounds show inhibitory potency against IMP-1. Two of them are found to have novel scaffolds, implying a good potential for further optimization.

Keywords